眼内レンズ（IOL）市場調査レポート、規模とシェア、成長機会、およびトレンド洞察分析―製品別、エンドユーザー別、および地域別―世界予測2024―2036 年

眼内レンズ（IOL） 市場分析

• According to the World Health Organization (WHO), over 94 million people suffer from cataracts, making it the leading cause of blindness and vision impairment.

Before the introduction of IOLs, cataract surgery required the removal of the cloudy natural lens, which often resulted in a significant decrease in the patient's vision. This made the advent of intraocular lenses essential, as they could provide patients with better visual capabilities. Furthermore, there was a need for a solution that could restore more natural, high-quality vision after cataract surgery. IOLs have improved visual outcomes and reduced distortion compared to the thick glasses previously used, improving the quality of life for patients.

• Similarly, in Japan, where one in 10 people is over 80 years old, the prevalence of cataracts and other visual disorders is high.

This will also encourage the adoption of intraocular lens solutions that provide patients with better quality vision.

According to our analysis of the intraocular lens ( IOL) market, the following market trends and factors are predicted to contribute to market growth:

• Rise in ageing population - With the rise in the ageing population worldwide, there has been a significant rise in the cases of cataracts. This is the main growth driver for the intraocular lens (IOL) market as older adults are more susceptible to cataracts and other eye-related diseases. Hence, the demand for cataract surgeries and intraocular lenses is on the rise.
  • According to our analysts, the population aged 65 and above is estimated to exceed 1.5 billion by 2050, which is expected to significantly increase the demand for intraocular lens (IOL) surgery. This will result in potential growth for the intraocular lens (IOL) market.
• Increasing Patient Awareness – Rising patient awareness globally about the available treatment options is poised to act as a key growth driver for the expansion of the Intraocular Lens (IOL) market. Treatment options such as Intraocular Lens (IOL) surgery are gaining widespread acceptance among patients, fuelling the market growth. Moreover, patients are seeking medical interventions to improve their quality of vision and maintain their health through such methods. These factors work together to drive the Intraocular Lens (IOL) market.

How will the Intraocular Lens ( IOL) market benefit market players in Japan?

The Japan intraocular lens (IOL) market offers significant lucrative opportunities for market players in the country. These opportunities are influenced by both domestic demand and international market trends such as various export activities and government support policies.

Japan is considered as one of the leading exporters of ophthalmic devices and equipment which may aid market players.

• For example, Japan exported ophthalmic equipment and instruments worth US$305 million in 2022, indicating the country’s huge exports of manufactured goods have the potential to tap into the global market.

In addition, Japan's Pharmaceuticals and Medical Devices Agency (PMDA) provides a supportive regulatory framework for approval and monitoring of medical devices, including IOLs. Such policies strengthen the ability of domestic companies to bring their products to the global market. All these factors support market players in the country.

Market Issues

The high cost of premium intraocular lenses (IOLs), such as multifocal and toric lenses, has typically been a major growth constraint for the expansion of the IOL market. Such procedures are also expensive for patients in developing countries, creating a barrier to their easy adoption.

競争力ランドスケープ

眼内レンズ（IOL）業界の概要と競争のランドスケープ

SDKI Analyticsの調査者によると、眼内レンズ（IOL）市場は、大企業と中小規模の組織といったさまざまな規模の企業間の市場競争により細分化されています。市場関係者は、製品や技術の発売、戦略的パートナーシップ、コラボレーション、買収、拡張など、あらゆる機会を利用して市場での競争優位性を獲得しています。

世界の眼内レンズ（IOL）市場の成長に重要な役割を果たす主要な主要企業には、Alcon Inc.、STAAR SURGICAL、SIFI S.p.A.、Hanita Lenses Ltd、HumanOptics Holding AGなどが含まれます。 さらに、日本の眼内レンズ（IOL）市場のトップ5プレーヤーは、HOYA Corporation、NIDEK CO., LTD.、Santen Pharmaceutical Co., Ltd.、Menicon Co., Ltd.、SEIKO OPTICAL PRODUCTS CO., LTD.などです。この調査には、世界の眼内レンズ（IOL）市場分析レポートにおける詳細な競合分析、企業概要、最近の動向、およびこれらの主要企業の主要な市場戦略が含まれています。

眼内レンズ（IOL）市場ニュース

• 2024年3月、Alcon Japan Co., Ltd.は、白内障治療用の多焦点眼内レンズ（IOL）の世界累計埋め込み本数を発表しました。
• 2024 年 2 月、Johnson & Johnson Medtechは、最新の老眼矯正眼内レンズ tecnis puresee を emea で発売しました。